Replies to post #4963 on Avid Bioservices Inc (CDMO)

[volgoat]

Has David King been using that expertise while at PPHM already?

F. David King
Vice President of Business Development

David King, Vice President of Business Development, has over 20 years of commercial experience in the biopharmaceutical industry, including sales, marketing and extensive business development experience. His expertise in this area has led to the completion of significant corporate partnering deals with industry partners. He has identified, negotiated and closed a wide range of transactions including out-license, in-license, co-promotion and joint development and marketing agreements. Mr. King has an extensive network of contacts at biopharmaceutical companies in North America, Europe and Asia. Mr. King was formerly employed with Medinox, Inc., in San Diego, where he served as Vice President, Corporate Development. Previously, Mr. King held several executive and management level positions at various pharmaceutical companies, including Maxim Pharmaceuticals, DepoTech Corporation (now SkyePharma Ltd.), and Glaxo Inc. (now GlaxoSmithKline). He began his pharmaceutical industry career in sales and marketing for Stuart Pharmaceuticals (now AstraZeneca). Mr. King holds a bachelor's degree in Business Administration from Goshen College in Goshen, IN.

[ahdofmytime]

Katie, the movie is "Hollywood" (or Outsourcewood) and the book, of course, is le Carre. A great writer I believe to be one of the few who are able write about the real world honestly, even in fiction. In this case, The Constant Gardner, his voice is more angry than it has been in any of his other previous books.

He's a guy with the knowledge of what humans can do to humanity for the sake of money and power. That's my take. But I am not an exec., just an aging baby boomer who thought the world would be a much better place by now.

A question for you: If there's another round of shady financing instead of a respectable licensing agreement, or some other reputable method of funding, how would you rate management in terms of competence, or even trust--in relation to our prospects as retail shareholders?

Anyone else care to chime in?